HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined costimulatory and leukocyte functional antigen-1 blockade prevents transplant rejection mediated by heterologous immune memory alloresponses.

AbstractBACKGROUND:
Recent evidence suggests that alloreactive memory T cells are generated by the process of heterologous immunity, whereby memory T cells arising in response to pathogen infection crossreact with donor antigens. Because of their diminished requirements for costimulation during recall, these pathogen-elicited allocrossreactive memory T cells are of particular clinical importance, especially given the emergence of costimulatory blockade as a transplant immunosuppression strategy.
METHODS:
We used an established model of heterologous immunity involving sequential infection of a naïve C57BL/6 recipient with lymphocytic choriomeningitis virus and vaccinia virus, followed by combined skin and bone marrow transplant from a BALB/c donor.
RESULTS:
We demonstrate that coupling the integrin antagonist anti-leukocyte functional antigen (LFA)-1 with costimulatory blockade could surmount the barrier posed by heterologous immunity in a fully allogeneic murine transplant system. The combined costimulatory and integrin blockade regimen suppressed proliferation of alloreactive memory T cells and attenuated their cytokine effector responses. This combined blockade regimen also promoted the retention of FoxP³⁺ Tregs in draining lymph nodes. Finally, we show that in an in vitro mixed lymphocyte reaction system using human T cells, the combination of belatacept and anti-LFA-1 was able to suppress cytokine production by alloreactive memory T cells that was resistant to belatacept alone.
CONCLUSIONS:
As an antagonist against human LFA-1 exists and has been used clinically to treat psoriasis, these findings have significant translational potential for future clinical transplant trials.
AuthorsWilliam H Kitchens, Divya Haridas, Maylene E Wagener, Mingqing Song, Mandy L Ford
JournalTransplantation (Transplantation) Vol. 93 Issue 10 Pg. 997-1005 (May 27 2012) ISSN: 1534-6080 [Electronic] United States
PMID22475765 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • B7 Antigens
  • CD40 Antigens
  • Lymphocyte Function-Associated Antigen-1
  • CD40 Ligand
Topics
  • Animals
  • B7 Antigens (antagonists & inhibitors)
  • Bone Marrow Transplantation (immunology)
  • CD40 Antigens (antagonists & inhibitors)
  • CD40 Ligand (antagonists & inhibitors)
  • Graft Rejection (prevention & control)
  • Graft Survival
  • Humans
  • Immunologic Memory
  • Lymph Nodes (immunology)
  • Lymphocyte Activation
  • Lymphocyte Function-Associated Antigen-1 (physiology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Skin Transplantation (immunology)
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: